| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | — | — |
| Gross Profit | $710K | — | — |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $221K | -51.1% | -47.0% |
| Operating Income | -$972K | -99.8% | +18.6% |
| Pre-tax Income | -$961K | -97.4% | +19.6% |
| Income Tax | -$3K | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $426K | +6913.7% | +123.6% |
| Accounts Receivable | $1.5M | — | — |
| Current Assets | $3.9M | — | +1924.4% |
| Current Liabilities | $6.3M | +832.8% | +1478.6% |
| Total Liabilities | $6.5M | +862.8% | +1529.3% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$503K | — | — |
| Capital Expenditures | $40K | — | — |
| Investing Cash Flow | $191K | — | — |
| Financing Cash Flow | $634K | — | — |
| Free Cash Flow | -$543K | — | — |
| — |
| Net Income | -$946K | -94.4% | +20.9% |
| EPS (Basic) | -$0.01 | +0.0% | +50.0% |
| $17.5M |
| +4026.1% |
| — |